Albany Molecular Research Inc. (AMRI) to Present at Jefferies 2020 Virtual London Healthcare Conference

Oct. 14, 2020 12:00 UTC



ALBANY, N.Y.--(BUSINESS WIRE)-- Albany Molecular Research, Inc. (AMRI), Inc., (AMRI), a leading global provider of advanced contract research, development and manufacturing solutions, today announced that its CEO and CFO will present a corporate overview at the Jefferies 2020 Virtual London Healthcare Conference.

The presentation, to be delivered by CEO John Ratliff and CFO Jason Knoblauch, will be recorded and made available on AMRI’s website. AMRI’s executive team will also be available throughout the conference, November 17-19, 2020, to meet virtually with their industry peers to discuss ways AMRI can support their healthcare-focused efforts.

For more information, contact AMRI.

About AMRI

AMRI, a contract research development and manufacturing organization, partners with the pharmaceutical and biotechnology industries to improve patient outcomes and quality of life. AMRI’s team combines scientific expertise and market-leading technology to provide a complete suite of solutions in discovery, development, analytical services, and API and drug product manufacturing.


Jane Byram
SCORR Marketing


Source: Albany Molecular Research, Inc.

Back to news